Annual Short Term Debt
$4.51 M
+$378.00 K+9.16%
December 31, 2024
Summary
- As of March 13, 2025, BBIO annual short term debt is $4.51 million, with the most recent change of +$378.00 thousand (+9.16%) on December 31, 2024.
- During the last 3 years, BBIO annual short term debt has fallen by -$432.00 thousand (-8.75%).
- BBIO annual short term debt is now -14.22% below its all-time high of $5.25 million, reached on December 31, 2020.
Performance
BBIO Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$4.51 M
-$94.00 K-2.04%
December 31, 2024
Summary
- As of March 13, 2025, BBIO quarterly short term debt is $4.51 million, with the most recent change of -$94.00 thousand (-2.04%) on December 31, 2024.
- Over the past year, BBIO quarterly short term debt has dropped by -$94.00 thousand (-2.04%).
- BBIO quarterly short term debt is now -39.54% below its all-time high of $7.45 million, reached on March 31, 2021.
Performance
BBIO Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
BBIO Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +9.2% | -2.0% |
3 y3 years | -8.8% | -2.0% |
5 y5 years | +100.0% | -2.0% |
BBIO Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -8.8% | +22.6% | -8.8% | +22.6% |
5 y | 5-year | -14.2% | -100.0% | -39.5% | -100.0% |
alltime | all time | -14.2% | -100.0% | -39.5% | -100.0% |
BridgeBio Pharma Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $4.51 M(+9.2%) | $4.51 M(-2.0%) |
Sep 2024 | - | $4.60 M(-0.5%) |
Jun 2024 | - | $4.62 M(+1.7%) |
Mar 2024 | - | $4.54 M(+10.1%) |
Dec 2023 | $4.13 M(+12.3%) | $4.13 M(-0.2%) |
Sep 2023 | - | $4.14 M(+9.6%) |
Jun 2023 | - | $3.78 M(+2.8%) |
Mar 2023 | - | $3.67 M(-0.0%) |
Dec 2022 | $3.67 M | $3.67 M(-9.1%) |
Sep 2022 | - | $4.04 M(-6.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $4.31 M(-1.2%) |
Mar 2022 | - | $4.36 M(-11.6%) |
Dec 2021 | $4.94 M(-6.0%) | $4.94 M(-1.2%) |
Sep 2021 | - | $5.00 M(+10.1%) |
Jun 2021 | - | $4.54 M(-39.1%) |
Mar 2021 | - | $7.45 M(+41.9%) |
Dec 2020 | $5.25 M(>+9900.0%) | $5.25 M(+45.2%) |
Sep 2020 | - | $3.62 M(-0.3%) |
Jun 2020 | - | $3.63 M(+44.5%) |
Mar 2020 | - | $2.51 M(>+9900.0%) |
Dec 2019 | $0.00 | $0.00 |
FAQ
- What is BridgeBio Pharma annual short term debt?
- What is the all time high annual short term debt for BridgeBio Pharma?
- What is BridgeBio Pharma annual short term debt year-on-year change?
- What is BridgeBio Pharma quarterly short term debt?
- What is the all time high quarterly short term debt for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly short term debt year-on-year change?
What is BridgeBio Pharma annual short term debt?
The current annual short term debt of BBIO is $4.51 M
What is the all time high annual short term debt for BridgeBio Pharma?
BridgeBio Pharma all-time high annual short term debt is $5.25 M
What is BridgeBio Pharma annual short term debt year-on-year change?
Over the past year, BBIO annual short term debt has changed by +$378.00 K (+9.16%)
What is BridgeBio Pharma quarterly short term debt?
The current quarterly short term debt of BBIO is $4.51 M
What is the all time high quarterly short term debt for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly short term debt is $7.45 M
What is BridgeBio Pharma quarterly short term debt year-on-year change?
Over the past year, BBIO quarterly short term debt has changed by -$94.00 K (-2.04%)